Form D Explorer
Mati Therapeutics Inc. · CIK 1574251

Report a data issueCitable research briefCompare issuerPrivate research collection

Mati Therapeutics Inc.

CIK 1574251 · Corporation · Inc. DELAWARE · AUSTIN, Texas · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $10,523,695 in the Oct 8, 2025 filing and $4,896,500 in the Jul 2, 2026 filing. The two records may concern different offerings. From Sep 23, 2025 to Jul 2, 2026, the explorer stores 2 original notices and 1 amendments.

Filings
3
Original notices
2
Amendments
1
Activity
Sep 23, 2025
through Jul 2, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 8, 2025 · DJul 2, 2026 · D/ALater minus earlier
Reported offering amount$10,523,695$4,896,500$-5,627,195
Reported amount sold$9,867,695$2,649,815$-7,217,880
Reported investor count—2—
Reported minimum investment$0$0$0

Earlier SEC source: 0001574251-25-000003 · Later SEC source: 0001574251-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Jul 2, 2026

Reported offering amount
$4,896,500
Reported exemptions
Rule 506(b)
Reported amount sold
$2,649,815

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (3)